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Evidence Updates provide a summary of selected new evidence published since the literature 
search was last conducted for the accredited guidance they relate to. They reduce the need 
for individuals, managers and commissioners to search for new evidence. Evidence Updates 
highlight key points from the new evidence and provide a commentary describing its strengths 
and weaknesses. They also indicate whether the new evidence may have a potential impact 
on current guidance. For contextual information, this Evidence Update should be read in 
conjunction with the relevant clinical guideline, available from the NICE Evidence Services 
topic page for infection control.  
Evidence Updates do not replace current accredited guidance and do not provide 
formal practice recommendations.  
NICE Evidence Services are a suite of services that provide online access to high quality, 
authoritative evidence and best practice. 
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Introduction 
This Evidence Update identifies new evidence that is relevant to, and may have a potential 
impact on, the following reference guidance: 
Surgical site infection. NICE clinical guideline 74 (2008).  
A search was conducted for new evidence from 13 April 2011 to 8 January 2013. A total of 
1639 pieces of evidence were initially identified. Following removal of duplicates and a series 
of automated and manual sifts, 26 items were selected for the Evidence Update (see 
Appendix A for details of the evidence search and selection process). An Evidence Update 
Advisory Group, comprising topic experts, reviewed the prioritised evidence and provided a 
commentary.  
Although the process of updating NICE guidance is distinct from the process of an Evidence 
Update, the relevant NICE guidance development centres have been made aware of the new 
evidence, which will be considered when guidance is reviewed. 
Other relevant information 
The Evidence Update makes reference to surgical site infection criteria as defined by the US 
Centers for Disease Control and Prevention: • Mangram AJ, Horan TC, Pearson ML et al. (1999) Guideline for prevention of surgical site 
infection (CDC). Infection Control and Hospital Epidemiology 20: 247–78 
Feedback 
If you have any comments you would like to make on this Evidence Update, please email 
contactus@evidence.nhs.uk 
                                                     
1
 NICE-accredited guidance is denoted by the Accreditation Mark  
1 
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Key points 
The following table summarises what the Evidence Update Advisory Group (EUAG) decided 
were the key points for this Evidence Update. It also indicates the EUAG’s opinion on whether 
the new evidence may have a potential impact on the current guidance listed in the 
introduction. For further details of the evidence behind these key points, please see the full 
commentaries. 
The section headings used in the table below are taken from the guidance. 
Evidence Updates do not replace current accredited guidance and do not provide 
formal practice recommendations.  
 
Potential impact 
on guidance 
Key point Yes No 
Preoperative phase  • The benefits of preoperative bathing or showering with antiseptics 
in preventing surgical site infection appear to be uncertain. 
Evidence for the most effective type of antiseptic wash also 
appears to be inconclusive, and further research is needed. 
 
• Evidence for preoperative hair removal in reducing surgical site 
infection rates is insufficient. If hair removal is necessary, then 
clipping may be associated with a reduced rate of infection. 
 
• Evidence for the effect of surgical teams wearing or removing 
finger rings and nail polish on surgical site infection rates 
is lacking.  
 
• Preoperative antibiotic prophylaxis plus antiseptic skin 
preparation may reduce surgical site infection risk after 
cardiac device implantation surgery (compared with no or 
postoperative antibiotics). 
 
• Antibiotic prophylaxis appears to reduce surgical site infection 
rates in elective open hernia repairs that use a mesh implant, but 
not in repairs performed without mesh. 
 
• Antibiotic prophylaxis in breast cancer surgery without 
reconstruction may reduce the risk of surgical site infection 
(although this does not take into account other issues such 
as the potential for drug reactions and increased bacterial 
antimicrobial resistance). 
 
• Evidence suggests that administering antibiotics after, rather than 
before, tourniquet inflation may be associated with a reduced rate 
of surgical site infection, but further research is needed. 
 
Intraoperative phase   • Evidence for the effect of surgical masks on surgical site infection 
rates is insufficient and more research is needed.  • The most effective antiseptic for skin preparation before surgical 
incision remains uncertain.  • Abdominal incision with diathermy appears to have no advantage 
over using a scalpel in reducing surgical site infection rates, but 
more research is needed. 
 
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Potential impact 
on guidance 
Key point Yes No • Perioperative oxygen supplementation does not appear to reduce 
surgical site infection rates, but more research is needed to 
investigate subgroups of patients for whom supplemented oxygen 
could be beneficial. 
 
• Haemodynamic goal-directed therapy (titration of fluid and 
inotropic drugs to reach normal or supraoptimal physiological 
endpoints such as cardiac output and oxygen delivery) appears to 
reduce surgical site infection rates. 
 
• Limited evidence suggests that a gentamicin-impregnated sponge 
may reduce rates of deep sternal wound infection after cardiac 
surgery via median sternotomy. 
 
• No particular dressing type emerges as the most effective in 
reducing risk of surgical site infection, although silver nylon 
dressings may be more effective than gauze. Further research to 
establish efficacy among modern dressing types is needed. 
 
• Risk of surgical site infection appears to be no different when leg 
wounds are closed with staples or with sutures after vein 
harvesting for coronary artery bypass grafting. 
 
• Antimicrobial-coated sutures may reduce surgical site infection risk 
versus uncoated sutures, although this effect may be specific to 
particular types of surgery (such as abdominal procedures).  * • Laparoscopy appears to be associated with lower rates of surgical 
site infection than open surgery among some subgroups; namely, 
obese patients, and those undergoing colorectal surgery. 
 
• Wound-edge protection devices may reduce surgical site infection 
rates after open abdominal surgery, but further research is 
needed. 
 
Postoperative phase   • Negative pressure wound therapy appears to reduce surgical site 
infection rates after invasive treatment of lower limb trauma, but 
may be less effective in other patient groups such as those with 
multiple comorbidities. Further research is needed. 
 
 
                                                     
* Evidence Updates are intended to increase awareness of new evidence and do not change the 
recommended practice as set out in current guidance. Decisions on how the new evidence may impact 
guidance will not be possible until the guidance is reviewed by NICE following its published processes 
and methods. For further details of this evidence in the context of current guidance, please see the full 
commentary. 
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1 Commentary on new evidence 
These commentaries analyse the key references identified specifically for the Evidence 
Update. The commentaries focus on the ‘key references’ (those identified through the search 
process and prioritised by the EUAG for inclusion in the Evidence Update), which are 
identified in bold text. Supporting references provide context or additional information to the 
commentary. Section headings are taken from the guidance. 
Glossary of terms 
The following terms are used to classify surgical wounds: 
Clean: an incision in which no inflammation is encountered in a surgical procedure, without a 
break in sterile technique, and during which the respiratory, alimentary or genitourinary tracts 
are not entered. 
Clean-contaminated: an incision through which the respiratory, alimentary, or genitourinary 
tract is entered under controlled conditions but with no contamination encountered. 
Contaminated: an incision undertaken during an operation in which there is a major break 
in sterile technique or gross spillage from the gastrointestinal tract, or an incision in which 
acute, non-purulent inflammation is encountered. Open traumatic wounds that are more than  
12–24 hours old also fall into this category. 
1.1 Information for patients and carers 
No new key evidence was found for this section. 
1.2 Preoperative phase 
Preoperative showering 
NICE CG74 recommends that patients should be advised to shower or have a bath (or be 
helped to have a shower, bath or bed bath) using soap, either the day before, or on the day 
of, surgery. Three reviews have recently assessed preoperative showering with antiseptics. 
A Cochrane review by Webster and Osborne (2012) evaluated randomised controlled trials 
(RCTs) comparing preoperative showering or bathing with any antiseptic, before any type of 
surgery in any setting, to reduce surgical site infection. A total of 7 RCTs (n=10,157) were 
identified, all of which examined chlorhexidine. 
For the primary outcome of surgical site infection (as defined by individual trial authors), 
preoperative showering or bathing with chlorhexidine was found to be no more effective than:  • placebo (relative risk [RR]=0.91, 95% CI 0.80 to 1.04, p=0.17; 4 RCTs, n=7791) • soap (RR=1.02, 95% CI 0.57 to 1.84; 3 RCTs, n=1443) • or no washing (RR=0.82, 95% CI 0.26 to 2.62; 3 RCTs, n=1142). 
Limitations of the evidence included that only 1 of the identified studies was published within 
the last 20 years, during which time practices may have changed. 
A systematic review by Jakobsson et al. (2011) examined the effects of the number of 
antiseptic showers, and type of antiseptic, on surgical site infection. Randomised and non-
randomised clinical trials of preoperative disinfection showers in any healthcare setting, 
examining outcomes of surgical site infection or level of skin bacteria, were included. Trials of 
disinfection of hands or materials were excluded. A total of 10 studies (n=7351) were 
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identified, which examined the effect of 1 shower (2 studies), 2 showers (5 studies), or 3 or 
more showers (3 studies). Most trials compared chlorhexidine with soap or placebo but 
differences between studies prevented meta-analysis.  
The authors stated that no definitive conclusion could be made about the optimal number of 
preoperative showers, but noted that in 8 of the studies, chlorhexidine led to a reduction in 
skin bacterial levels. However, skin bacteria do not necessarily correlate with surgical site 
infection risk. Limitations of most studies included that the number of showers was of 
secondary interest and the showering process was not explicitly described. Additionally, of the 
included studies, only 4 were assessed as being high quality evidence, 4 involved 60 or fewer 
participants, and only 1 was published within the last 20 years during which time practices 
may have changed. 
A systematic review by Kamel et al. (2012) also evaluated preoperative antiseptics for 
preventing surgical site infections. Randomised and non-randomised studies of 3 types of 
skin antiseptic (iodophors, alcohol, or chlorhexidine) used before thoracic, cardiac, plastic, 
orthopaedic, neurological, abdominal, or pelvic surgery were included. A total of 20 studies 
(n=9520) were identified, examining: one antiseptic versus another (9 studies), antiseptic 
showers (7 studies), iodophor incise drapes (3 studies), and antiseptic versus soap, alcohol or 
saline (2 studies). Heterogeneity between studies prevented meta-analysis. 
The authors stated that based on results from 3 RCTs and 4 cohort studies (n=2512), 
preoperative showering appeared to reduce skin bacterial levels, but that the effect on 
surgical site infection was inconclusive. They also stated that conclusions about the most 
effective antiseptic could not be made.  
Limitations of the evidence included that:  • formulation, strength and application of antiseptics were inconsistent among studies • the included studies were of mixed quality and randomisation was often poorly reported • a wide range of procedures were included limiting conclusions about specific patient 
groups. 
Taken together, these studies indicate that the benefits of preoperative bathing or showering 
with antiseptics in preventing surgical site infection appear to be uncertain. Evidence for the 
most effective type of antiseptic wash also appears to be inconclusive. These data are 
unlikely to affect recommendations in NICE CG74 to have a shower or bath with soap before 
surgery. Further robust evidence is needed from large trials to compare no showering versus 
single or multiple showers, including comparisons of soap versus a range of antiseptics. 
Key references 
Jakobsson J, Perlkvist A, Wann-Hansson C (2011) Searching for evidence regarding using preoperative 
disinfection showers to prevent surgical site infections: a systematic review. Worldviews on Evidence-
Based Nursing 8: 143–52 
Kamel C, McGahan L, Polisena J et al. (2012) Preoperative skin antiseptic preparations for preventing 
surgical site infections: a systematic review. Infection Control & Hospital Epidemiology 33: 608–17 
Webster J, Osborne S (2012) Preoperative bathing or showering with skin antiseptics to prevent surgical 
site infection. Cochrane Database of Systematic Reviews issue 9: CD004985 
Hair removal 
NICE CG74 states: do not use hair removal routinely to reduce the risk of surgical site 
infection, and do not use razors for hair removal, because they increase the risk of surgical 
site infection. If hair has to be removed, use electric clippers with a single-use head on the 
day of surgery. 
A Cochrane review by Tanner et al. (2011) investigated preoperative hair removal to reduce 
surgical site infection. RCTs and quasi-RCTs examining a primary outcome of hair removal 
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versus no hair removal, and secondary outcomes of different methods, settings, and timings 
of hair removal before surgery, were included. A total of 14 trials (n=3838) were identified. 
For the primary outcome, a comparison of shaving (of either body or scalp hair) versus no 
hair removal found no significant difference in rates of surgical site infection between groups 
(RR=1.75, 95% CI 0.93 to 3.28, p=0.084; 4 RCTs, n=575). A non-significant difference in 
infection rate was also seen with clipping scalp hair versus no hair removal (RR=1.00, 95% CI 
0.06 to 15.65, p=1.0; 1 RCT, n=130). When shaving was compared with clipping (of either 
body or scalp hair), significantly more surgical site infections were seen with shaving 
(RR=2.03, 95% CI 1.14 to 3.61, p=0.017; 3 RCTs, n=1343). 
Limitations of the evidence included that:  • some comparisons were underpowered • the methodological quality and reporting for most of the included trials was described as 
poor • none of the trials used standardised definitions of surgical site infection • only 2 of the 14 trials were published within the last 20 years, during which time practices 
may have changed. 
The authors concluded that evidence for preoperative hair removal in reducing surgical site 
infection rate is insufficient. If hair removal is necessary, then clipping may be associated with 
a reduced rate of infection. This is consistent with current recommendations in NICE CG74. 
Key reference 
Tanner J, Norrie P, Melen K (2011) Preoperative hair removal to reduce surgical site infection. 
Cochrane Database of Systematic Reviews issue 11: CD004122 
Hand jewellery, artificial nails and nail polish 
NICE CG74 recommends that the operating team should remove hand jewellery, artificial 
nails and nail polish before operations.  
A Cochrane review by Arrowsmith and Taylor (2012) examined the effects of wearing or 
removing nail polish and finger rings among surgical scrub teams on postoperative surgical 
site infection. No trials were found for the primary outcome of infection rate. A single RCT 
(n=102) was identified evaluating a secondary outcome of whether nail polish, worn by scrub 
nurses, affected the number of bacterial colony forming units on hands after scrubbing before 
surgery (only the dominant hand was tested). No significant differences in the number of 
bacteria on hands before or after scrubbing were seen between nurses with either unpolished 
nails, recently applied nail polish (less than 2 days old), or old nail polish (more than 4 days 
old).  
Limitations of the evidence included that only 1 small trial, examining a secondary outcome, 
was identified (which the authors stated was underpowered to detect clinically important 
differences). The authors concluded that there is a lack of evidence for the effect of surgical 
teams wearing or removing finger rings and nail polish on surgical site infection rates. 
Evidence of the impact of nail polish on skin bacterial levels is also insufficient; therefore 
these data are unlikely to affect NICE CG74. 
Key reference 
Arrowsmith VA, Taylor R (2012) Removal of nail polish and finger rings to prevent surgical infection. 
Cochrane Database of Systematic Reviews issue 5: CD003325 
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Antibiotic prophylaxis 
NICE CG74 recommends giving antibiotic prophylaxis to patients before: • clean surgery involving the placement of a prosthesis or implant • clean-contaminated surgery  • contaminated surgery.  
Antibiotic prophylaxis should not be used routinely for clean non-prosthetic uncomplicated 
surgery. 
Antibiotics in cardiac device implantation surgery 
A systematic review and meta-analysis by Darouiche et al. (2012) investigated the use of 
prophylactic antibiotics and antiseptics to prevent surgical site infection after implantation of 
an electronic cardiac device. RCTs of perioperative antiseptics and antibiotics (local or 
systemic), alone or combined, during initial or repeat implantation of pacemakers or 
cardioverter-defibrillators, were included. A total of 15 studies (n=3970) were identified. The 
primary outcome of surgical site infection included septicaemia, septic shock, infective or 
bacterial endocarditis, valve infection, and cellulitis. 
A significant reduction in the incidence of surgical site infection was seen after systemic 
antibiotics plus skin antisepsis 1 hour before surgery, versus either no antibiotics (RR=0.13, 
95% CI 0.05 to 0.36, p<0.00001; 6 RCTs, n=1766), or postoperative antibiotics (RR=0.14, 
95% CI 0.03 to 0.60, p=0.008; 1 RCT, n=100). 
Limitations of the evidence included that:  • the quality of most studies was assessed as poor to moderate • only 5 studies used the criteria for surgical site infection as set out by the US Centers for 
Disease Control and Prevention • various antibiotics were used across the trials (with some used in isolation and some in 
combination) therefore conclusions about specific antibiotics could not be made • the wide inclusion criteria of antibiotics and antiseptics in any combination made it difficult 
to draw conclusions about either antimicrobial technique. 
The evidence suggests that preoperative antibiotic prophylaxis plus antiseptic skin 
preparation may reduce surgical site infection risk after cardiac device implantation surgery 
(compared with no or postoperative antibiotics). This is consistent with recommendations in 
NICE CG74 for antibiotic prophylaxis in clean surgery using an implant. 
Key reference 
Darouiche R, Mosier M, Voigt J (2012) Antibiotics and antiseptics to prevent infection in cardiac rhythm 
management device implantation surgery. Pacing and Clinical Electrophysiology 35: 1348–60 
Antibiotics in hernia repair 
A Cochrane review by Sanchez-Manuel et al. (2012) assessed the effect of antibiotic 
prophylaxis on surgical site infection rates after hernia repair. RCTs of antibiotic prophylaxis 
among adult patients undergoing elective open inguinal or femoral hernia repair, with either 
herniorrhaphy (non-mesh repair) or hernioplasty (mesh repair) were included. Trials of 
laparoscopic repair, and those using antiseptic prophylaxis, were excluded. A total of 
17 RCTs (n=7843) were identified. The primary outcome was surgical site infection as defined 
by individual trial authors. 
Overall, surgical site infection rate was significantly lower with antibiotic prophylaxis than 
control (3.1% versus 4.5% respectively; OR=0.64, 95% CI 0.50 to 0.82, p=0.00042; 17 RCTs, 
n=7843). Subgroup analysis indicated that infection rates after herniorrhaphy were not 
significantly different between the antibiotic and control groups (3.5% versus 4.9% 
respectively; OR=0.71, 95% CI 0.51 to 1.00, p=0.052; 6 RCTs, n=4269). However, after 
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hernioplasty, infection rates were significantly lower with antibiotics than control (2.4% versus 
4.2% respectively; OR=0.56, 95% CI 0.38 to 0.81, p=0.0023; 11 RCTs, n=3574).  
Limitations of the evidence included that:  • although most studies used treatments relevant to modern practice, some of the older 
studies involved antibiotics that may now be considered inappropriate (such as ampicillin) • a wide variety of antibiotics were used across the trials, so no conclusions about efficacy 
of particular antibiotics could be made • adverse events or bacterial resistance after using antibiotics were not considered by the 
review • laparoscopic procedures were not included so the conclusions relate only to open 
surgery. 
The evidence suggests that antibiotic prophylaxis appears to reduce surgical site infection 
rates in elective open hernia repairs that use a mesh implant, but not in repairs performed 
without mesh. This is consistent with recommendations in NICE CG74 to use antibiotic 
prophylaxis in clean surgery involving an implant. 
Key reference 
Sanchez-Manuel FJ, Lozano-García J, Seco-Gil JL (2012) Antibiotic prophylaxis for hernia repair. 
Cochrane Database of Systematic Reviews issue 2: CD003769 
Antibiotics in breast cancer surgery 
Two studies recently assessed antibiotic prophylaxis to prevent surgical site infection after 
breast cancer surgery. 
A Cochrane review by Bunn et al. (2012) examined RCTs and controlled trials of patients 
undergoing breast cancer surgery (with or without immediate reconstruction) that compared 
preoperative or perioperative antibiotic prophylaxis with none or placebo. A total of 7 studies 
(n=1945) were identified, none of which included reconstructive surgery.  
For the primary outcome of surgical site infection, a significantly reduced incidence of 
infection was seen with prophylactic antibiotics compared with no antibiotics or placebo 
(RR=0.72, 95% CI 0.53 to 0.97, p=0.031; 7 studies, n=1945).  
Limitations of the evidence included that: no trials involved reconstructive surgery so results 
only apply to procedures without reconstruction; and various antibiotics were used across the 
trials therefore conclusions about specific antibiotics could not be made. 
A double-blind RCT (n=254) in the Philippines by Cabaluna et al. (2013) also investigated 
antibiotic prophylaxis in breast cancer surgery. Patients were randomised to placebo or to 
active treatment (1 g intravenous cefazolin2
The trial included women with breast cancer (Eastern Cooperative Oncology Group score 0–
1, clinical stage I to IIIC), undergoing elective modified radical mastectomy at a single tertiary 
hospital. Exclusion criteria were: recurrent breast cancer; previous radiotherapy; diabetes 
mellitus or severe malnutrition; corticosteroid therapy; simultaneous breast reconstruction or 
bilateral oophorectomy; antibiotic treatment within 1 week before surgery; allergy to 
cephalosporins; and existing local infection. Surgical site infection was defined according to 
the US Centers for Disease Control and Prevention criteria.  
 in 10 ml sterile water 30 minutes before incision), 
and all patients received preoperative povidone-iodine antiseptic skin preparation. After 
surgery, all patients had a drain fitted, their incisions closed with staples or Vicryl sutures, and 
sterile dressings applied. Wounds were assessed on the day after surgery, before discharge, 
then weekly for 4 weeks at a breast care centre.  
                                                     
2
 Cefazolin did not have UK marketing authorisation for perioperative prophylaxis at the time of 
publication of this Evidence Update.  
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For the primary outcome of surgical site infection within 30 days, there was no difference in 
infection rate between the placebo group (19/127; 15.0%) and the antibiotic group (17/127; 
13.4%; p=0.719). The authors then added the results of their trial to the meta-analysis from 
the Cochrane review by Bunn et al. (2012) discussed above. The overall significance of the 
meta-analysis did not change, which still favoured antibiotics. However, the authors 
performed a further meta-analysis combining the results of their RCT with a subset of studies 
from the Cochrane review that principally considered mastectomy (including wide local 
excision). The effect of antibiotic prophylaxis on infections was no longer significant for this 
patient group (RR=0.84, 95% CI 0.61 to 1.17, p = 0.31; 5 studies, n=1050). 
Limitations of the evidence included that:  • 40 different surgeons with a wide range of experience carried out the procedures, which 
increased the potential for inter-operator variability (however, this could improve the 
generalisability of results outside of the trial) • the amount of postoperative infection was at the higher end of reported rates, suggesting 
that other variables may have influenced outcomes • postoperative care of drains by patients was not assessed, which may have affected 
infection rates. 
Taken together, the evidence suggests that antibiotic prophylaxis in breast cancer surgery 
without reconstruction may reduce the risk of surgical site infection. However, other issues 
such as cost, and the potential for drug reactions and increased bacterial antimicrobial 
resistance, are also important considerations. The potential for adverse outcomes with 
overuse of antibiotics means that this evidence is unlikely to affect recommendations NICE 
CG74 not to use antibiotics in clean non-prosthetic surgery. 
Key references 
Bunn F, Jones DJ, Bell-Syer S (2012) Prophylactic antibiotics to prevent surgical site infection after 
breast cancer surgery. Cochrane Database of Systematic Reviews issue 1: CD005360 
Cabaluna ND, Uy GB, Galicia RM et al. (2013) A randomized, double-blinded placebo-controlled clinical 
trial of the routine use of preoperative antibiotic prophylaxis in modified radical mastectomy. World 
Journal of Surgery 37: 59–66 
Antibiotics in tourniquet surgery 
NICE CG74 recommends that when antibiotic prophylaxis is needed, a single dose of 
antibiotic intravenously on starting anaesthesia should be considered. However, prophylaxis 
should be given earlier for operations in which a tourniquet is used. 
An RCT (n=106) in Nigeria by Akinyoola et al. (2011) investigated the effect of administering 
antibiotics before and after tourniquet application on surgical site infection. Consecutive 
patients at a single hospital, who were undergoing clean, elective orthopaedic surgery on the 
lower limb involving a tourniquet, were included. Patients (matched for age, sex, and 
operation type) were randomised to intravenous cefuroxime administered either 5 minutes 
before limb exsanguination and tourniquet inflation, or 1 minute after tourniquet inflation 
(followed in all cases by 3 postoperative antibiotic doses, 8 hours apart). All patients received 
general anaesthesia (except 2 who were given spinal anaesthesia), and had the tourniquet 
applied to their thigh. 
Most procedures (72%) were open reduction and internal fixation of fractures (with the 
remainder being mainly soft tissue releases). There was no significant difference in the types 
of procedure carried out between the groups (p=0.332). Patients were followed up for at least 
12 months, and surgical site infection (defined as spontaneous pus drainage after suture 
removal or in association with overt wound dehiscence) was determined by the 2 operating 
surgeons. Visual analogue scoring of the wound was also performed independently by a 
 Evidence Update 43 – Surgical site infection (June 2013) 13 
senior registrar in another unit for 28 days after surgery, although it was not clear whether this 
was used to inform diagnosis of infection. 
Significantly fewer surgical site infections were seen in the group who received antibiotics 
after tourniquet inflation (2/52; 3.9%) than among those who were given antibiotics before 
inflation (8/54; 14.8%; p=0.031).  
Limitations of the evidence included that:  • the surgeons performing the operations were also involved in diagnosing wound infection, 
which may have been a source of bias • some soft tissue operations were included that would not routinely involve antibiotic 
prophylaxis under NICE guidance • no data about the timing of tourniquet release were provided, which may also have been 
a factor in the outcomes seen. 
The evidence suggests that administering antibiotics after, rather than before, tourniquet 
inflation may be associated with a reduced rate of surgical site infection. This is opposite to 
the practice currently recommended in NICE CG74, but limitations of the evidence mean that 
further research in larger trials is needed to confirm findings. This evidence is therefore 
unlikely to affect current guidance. 
Key reference 
Akinyoola AL, Adegbehingbe OO, Odunsi A (2011) Timing of antibiotic prophylaxis in tourniquet surgery. 
Journal of Foot & Ankle Surgery 50: 374–6 
1.3 Intraoperative phase 
Surgical face masks 
Although NICE CG74 recommends that the operating team should wear sterile gowns in the 
operating theatre during the operation, no recommendations are made specifically about the 
use of surgical face masks in preventing surgical site infection. 
A Cochrane review by Lipp and Edwards (2012) examined whether face masks can prevent 
surgical site infection. RCTs and quasi-RCTs that compared infection rates with and without 
the use of disposable face masks, among surgical teams performing clean surgery, were 
included. A total of 3 trials (n=2113) were identified, but heterogeneity prevented meta-
analysis.  
For the primary outcome of effect on postoperative surgical wound infection (as defined by 
individual trial authors), no significant effect of wearing masks versus not wearing masks was 
seen in any of the 3 trials identified.  
Limitations of the evidence included that:  • a wide range of types of surgery were included with no sub-analysis of specific types • none of the studies measured compliance with correct mask wearing • type of theatre ventilation used (such as conventional versus ultraclean) was not 
considered, which may have affected infection rates • type of mask was specified in only 1 study • the studies were published between 1986 and 2010, during which time mask design may 
have changed. 
The authors concluded that evidence to assess the effect of surgical masks on surgical site 
infection rates was insufficient and more research is needed. Therefore, this evidence is 
unlikely to affect NICE CG74. However, there are other reasons for wearing masks beside 
infection prevention, particularly as part of personal protective equipment for theatre staff. The 
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full version of NICE CG74 noted that the issue of operating staff protection was beyond the 
scope of the guideline and is covered by health and safety regulations. 
Key reference 
Lipp A, Edwards P (2012) Disposable surgical face masks for preventing surgical wound infection in 
clean surgery. Cochrane Database of Systematic Reviews issue 1: CD002929 
Antiseptic skin preparation 
NICE CG74 recommends preparing the skin at the surgical site immediately before incision 
using an antiseptic (aqueous or alcohol-based) preparation: povidone-iodine or chlorhexidine 
are most suitable. Two reviews recently compared antiseptic skin preparations. 
A Cochrane review by Hadiati et al. (2012) compared different types of preoperative skin 
preparation for preventing infection after caesarean section. Randomised, quasi-randomised, 
and cluster-randomised trials, evaluating any type of skin preparation of the incision area 
before elective or emergency caesarean section, were included. Studies of preoperative hand 
washing or bathing were excluded. A total of 5 trials (n=1462) were identified. Two trials 
compared incisional drapes with no drapes in women who had all received the same 
preoperative skin disinfection, and 3 trials compared different antiseptic preparations. 
In women who had received skin preparation preoperatively (with either iodine or 
chlorhexidine, though these antiseptics were not compared directly), the use of drapes versus 
no drapes did not make a significant difference to the primary outcome of surgical site 
infection (RR=1.29, 95% CI 0.97 to 1.71, p=0.084; 2 trials, n=1294). There was also no 
significant difference in infection with parachlorometaxylenol plus iodine versus iodine alone 
(RR=0.33, 95% CI 0.04 to 2.99, p=0.33; 1 trial, n=50). A single trial (n=79) comparing alcohol 
scrub plus iodophor drape versus iodophor scrub without drape reported no infections in 
either group. 
Limitations of the evidence included the small number of trials identified, and the 
heterogeneity of disinfection methods which made pooling of data difficult. The authors 
concluded that there was insufficient evidence to determine the most effective type of skin 
preparation before caesarean section in preventing surgical site infection.  
The systematic review by Kamel et al. (2012) (see ‘Preoperative showering’ in Section 1.2 for 
details) also examined antiseptic skin preparations. Based on mixed results from 5 RCTs, 
2 cohort studies, and 2 case control-studies, the authors stated that conclusions about the 
most effective antiseptic could not be made. This review included an RCT (n=849) by 
Darouiche et al. (2010) that specifically compared chlorhexidine with povidone-iodine 
antisepsis before clean-contaminated surgery. The results indicated that an alcohol-based 
solution of chlorhexidine appeared to be superior for preventing surgical site infection. 
Evidence from this RCT was noted during the decision whether to review NICE CG74 in 
2011, but it was considered insufficient to warrant an update of the guideline at that time. 
Taken together, current evidence suggests that the most effective antiseptic for skin 
preparation before surgical incision remains uncertain. These data are unlikely to affect 
recommendations in NICE CG74 to use either povidone-iodine or chlorhexidine, though 
alcohol-based solutions may be more effective than aqueous solutions.  
Key reference 
Hadiati DR, Hakimi M, Nurdiati DS (2012) Skin preparation for preventing infection following caesarean 
section. Cochrane Database of Systematic Reviews issue 9: CD007462 
Supporting reference 
Darouiche RO, Wall MJ Jr, Itani KM et al. (2010) Chlorhexidine-alcohol versus povidone-iodine for 
surgical-site antisepsis. New England Journal of Medicine 362: 18–26 
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Diathermy 
NICE CG74 states: do not use diathermy for surgical incision to reduce the risk of surgical site 
infection. 
A Cochrane review by Charoenkwan et al. (2012) investigated the effect of abdominal 
incision with either scalpel or electrodiathermy on overall wound complications. RCTs 
comparing rates of wound complications (incorporating several outcome measures, including 
infection) among patients undergoing major open abdominal surgery, regardless of incision 
orientation or surgical setting, were included. Quasi-RCTs were excluded. A total of 9 RCTs 
(n=1901) were identified. 
From the studies reporting data for the primary outcome of overall wound complication rate, 
no difference was seen between patients whose abdominal incisions were made with 
diathermy or with a scalpel (RR=0.90, 95% CI 0.68 to 1.18, p=0.44; 7 RCTs, n=1559).  
Limitations of the evidence included:  • incomplete reporting by most trials, and substantial heterogeneity among trials • the use of a combined outcome of overall wound complications in the meta-analysis 
(although most of the RCTs contributing to it did examine wound infection as an 
outcome);  • only 174 instances of wound complication were recorded among the 1559 patients 
included in the meta-analysis, therefore the analysis may have been underpowered. 
Evidence suggests that abdominal incision with diathermy appears to have no advantage 
over using a scalpel in reducing wound complications, but more research is needed. This is 
consistent with current recommendations in NICE CG74 not to use diathermy for surgical 
incision to reduce surgical site infection risk. 
Key reference 
Charoenkwan K, Chotirosniramit N, Rerkasem K (2012) Scalpel versus electrosurgery for abdominal 
incisions. Cochrane Database of Systematic Reviews issue 6: CD005987 
Maintaining patient homeostasis 
Perioperative oxygen supplementation 
NICE CG74 recommends maintaining optimal oxygenation during surgery. In particular, 
patients should be given sufficient oxygen during major surgery and in the recovery period to 
ensure that a haemoglobin saturation of more than 95% is maintained. However, it does not 
make any recommendations about the use of perioperative high inspired oxygen therapy in 
preventing surgical site infection. 
A systematic review and meta-analysis by Togioka et al. (2012) examined the role of 
perioperative oxygen supplementation in reducing surgical site infection. RCTs in adult 
populations comparing the perioperative use of supplemented compared with control oxygen 
concentrations were included. Studies of hyperbaric ventilation were excluded. A total of 
7 RCTs (n=2728) were identified. In all 7 of the included trials, the supplemented oxygen 
group received 80% oxygen during surgery (plus at least 2 hours postoperatively), and the 
control groups were given either 30% or 35% oxygen.  
No significant difference was seen in the primary outcome of surgical site infection rate (as 
defined by individual trial authors) between the supplemented oxygen and control groups 
(15.5% versus 17.5% respectively; odds ratio=0.85, 95% CI 0.52 to 1.38, p=0.51; 7 RCTs, 
n=2728). Several sensitivity analyses (excluding: the largest study; the lowest quality study; 
the study with an opposite result to other studies; and studies that included nitrous oxide, or 
that mandated either aggressive or conservative fluid management) did not alter the overall 
conclusion. However, 2 subgroup analyses did show a significant benefit of supplemented 
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oxygenation on surgical site infections. Namely, when studies of neuraxial anaesthesia were 
excluded (OR=0.66, 95% CI 0.46 to 0.93, p=0.02; 5 RCTs, n=1199); and when studies of 
colorectal surgery only were included (OR=0.48, 95% CI 0.32 to 0.71, p=0.0003; 4 RCTs, 
n=1039).  
Limitations of the evidence included some heterogeneity among the included trials, for 
example with: antibiotic use, definition of surgical site infection, patient population, and 
duration of perioperative oxygen supplementation.  
NICE CG74 included a research recommendation about the value of supplemented 
oxygenation, and this review suggests that perioperative oxygen supplementation does not 
appear to reduce surgical site infection rate. The evidence is unlikely to affect the 
recommendation in NICE CG74 to give sufficient oxygen to maintain a haemoglobin 
saturation of more than 95%. However, as indicated by the subanalyses in which neuraxial 
anaesthesia was excluded, and colorectal surgery only was included, there may be 
subgroups of patients for whom supplemented oxygenation could be beneficial. Further 
research to examine subgroups (incorporating appropriate monitoring of patient response in 
achieving optimal homeostasis) is needed. 
Key reference 
Togioka B, Galvagno S, Sumida S et al. (2012) The role of perioperative high inspired oxygen therapy in 
reducing surgical site infection: a meta-analysis. Anesthesia & Analgesia 114: 334–42 
Haemodynamic goal-directed therapy 
NICE CG74 recommends maintaining optimal oxygenation and adequate perfusion during 
surgery. It does not make any recommendations specifically about the use of haemodynamic 
goal-directed therapy (a haemodynamic treatment based on titration of fluid and inotropic 
drugs to reach normal or supraoptimal physiological endpoints such as cardiac output and 
oxygen delivery). 
A systematic review and meta-analysis by Dalfino et al. (2011) assessed the effect of 
haemodynamic goal-directed therapy on surgical site infection rates. RCTs of goal-directed 
versus standard haemodynamic therapy in patients undergoing major surgery were included. 
Goal-directed therapy was defined as perioperative monitoring and manipulation of 
haemodynamic parameters to reach normal or supraoptimal values by fluid infusion alone or 
in combination with inotropic therapy within 8 hours after surgery.  
Studies were excluded if:  • they involved mixed populations of critically ill, non-surgical, or postoperative patients with 
sepsis or organ failure • they used late haemodynamic optimisation treatment • there was no description of, or no difference in, optimisation strategies between groups • therapy was titrated to the same goal in both groups, or not titrated to predefined end 
points.  
One of the primary outcomes of the review was surgical site infection (either incisional and 
organ or space). A total of 26 RCTs (n=4188) were identified involving abdominal (21 trials), 
cardiac (3 trials) and orthopaedic (2 trials) surgery. 
Goal-directed therapy appeared to significantly reduce surgical site infection rate compared 
with standard therapy (OR=0.58, 95% CI 0.46 to 0.74, p<0.0001; 18 RCTs, n=3550). Similarly 
significant effects were also seen in sensitivity analyses of: only trials at low risk of bias 
(14 RCTs; p<0.0001); only high-risk patients (13 RCTs; p=0.0001); and only studies using 
definitions of surgical site infection consistent with US Centers for Disease Control and 
Prevention criteria (8 RCTs; p=0.0001). 
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Limitations of the evidence included: heterogeneity among trials in the monitoring equipment 
used, the patients, the type and timing of interventions, and in the nature and level of targets; 
and that the type of control haemodynamic therapy used across the trials was not discussed 
in the review. 
The evidence suggests that haemodynamic goal-directed therapy appears to reduce surgical 
site infection rates, which is broadly consistent with recommendations in NICE CG74 to 
maintain optimal oxygenation and adequate perfusion during surgery. 
It should also be noted that intraoperative fluid management is a high impact innovation (as 
set out by the Department of Health’s 2011 report ‘Innovation Health and Wealth, 
Accelerating Adoption and Diffusion in the NHS’), and is also a Commissioning for quality and 
innovation (CQUIN) pre-qualification criterion for 2013/14.  
Additional information about the review by Dalfino et al. (2011) is also available in an 
independent critical appraisal report produced for the Centre for Reviews and Dissemination’s 
Database of Abstracts of Reviews of Effects.  
Key reference 
Dalfino L, Giglio MT, Puntillo F et al. (2011) Haemodynamic goal-directed therapy and postoperative 
infections: earlier is better. A systematic review and meta-analysis. Critical Care 153: R154 
Supporting reference 
Centre for Reviews and Dissemination (2012) Haemodynamic goal-directed therapy and postoperative 
infections: earlier is better. A systematic review and meta-analysis. Database of Abstracts of Reviews of 
Effects 
Antiseptic and antimicrobial agents before wound closure 
Although NICE CG74 makes recommendations about the use of intraoperative topical skin 
disinfection to reduce the risk of surgical site infection, it does not make any 
recommendations about the use of antimicrobial implants before wound closure. 
A double-blind RCT (n=720) in Germany by Schimmer et al. (2012) examined the use of a 
retrosternal gentamicin-collagen sponge in reducing wound complications after heart surgery. 
Patients aged 18 years or over at a single hospital, undergoing elective or emergency cardiac 
surgery via median sternotomy (first or resternotomy), and with no preoperative signs of 
thoracic inflammation, were included. Exclusion criteria were: existing osteitis, allergy to 
aminoglycoside antibiotics, immunosuppressive therapy, immunological disease, and 
pregnant or lactating women. Patients were randomised to implantation with a collagen 
sponge (placebo) or an identical sponge containing 2 mg gentamicin sulphate. The sponges 
were implanted retrosternally after preliminary placement of the sternal wiring, and the 
sternum was then wired and closed. The wound was sutured and then covered with a sterile 
dressing. All patients received intravenous cefuroxime 30 minutes before surgery and for up 
to 48 hours after. Patients were examined daily until discharged for signs of deep sternal 
wound infection (as defined by the US Centers for Disease Control and Prevention criteria).  
For the primary outcome of deep sternal wound infection within 30 days, significantly fewer 
infections were seen after using the gentamicin sponge (2/353; 0.56%) than the placebo 
sponge (13/367; 3.52%; p=0.014). There was however no significant difference in the 
incidence of superficial sternal wound infection between the gentamicin (7/353; 1.98%) and 
placebo groups (11/367; 2.98%; p=0.47). 
Limitations of the evidence included that:  • 80 patients were lost after randomisation (40 after revision surgery of bleeding, 20 after 
use of the wrong sponge, and 20 deaths) • most patients (52.9%) underwent coronary artery bypass grafting but the type of vein 
used was not specified, which may have affected infection rates 
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• the trial did not examine the potential of the sponge as a source or promoter of infection, 
for example by including a 3rd
The evidence suggests that a gentamicin-impregnated sponge may reduce rates of deep 
sternal wound infection after cardiac surgery via median sternotomy, but limitations of the 
evidence mean that results are unlikely to affect 
 arm with no sponge. 
NICE CG74. The full version of NICE CG74 
made the following research recommendation: ‘What is the cost effectiveness of collagen 
implants with antibiotics or antiseptics in the reduction in the incidence of surgical site 
infection?’ This RCT did not examine cost effectiveness of the intervention. 
Key reference 
Schimmer C, Ozkur M, Sinha B et al. (2012) Gentamicin-collagen sponge reduces sternal wound 
complications after heart surgery: a controlled, prospectively randomized, double-blind study. Journal of 
Thoracic and Cardiovascular Surgery 143: 194–200 
Wound dressings 
NICE CG74 recommends covering surgical incisions with an appropriate interactive dressing 
at the end of the operation. However, it does not make any recommendations about specific 
types of dressing. 
All dressings 
A Cochrane review by Dumville et al. (2011) investigated wound dressings in the prevention 
of surgical site infections. RCTs that compared either different wound dressings, or dressing 
versus no dressing, in patients with postoperative wounds (of any contamination level) 
healing by primary intention, were included. Dressings must have been applied in the 
operating theatre. Trials of procedures involving graft sites, or in which patients had infected 
wounds at baseline, were excluded. A total of 16 RCTs (n=2578) were identified. 
The authors stated that among the included trials, there was no evidence that covering 
wounds reduced the primary outcome of rate of surgical site infection (as defined by the US 
Centers for Disease Control and Prevention criteria, or individual trial authors), and that no 
particular wound dressing appeared to be better than any others, or than leaving the wound 
uncovered. 
Limitations of the evidence included that:  • most modern dressings were compared only with basic wound contact dressings such as 
gauze or absorbent dressings, therefore performance versus other modern types was not 
clear • many trials were small, and most studies were either assessed as poor quality, or could 
not be assessed because of incomplete reporting • only 4 of the 16 studies were published within the last 10 years, during which time 
practices may have changed. 
The authors concluded that in the absence of clear evidence of benefit of any particular 
dressing type on surgical site infection risk, wound dressings should be chosen on the basis 
of cost and the properties of the dressing. This evidence is unlikely to affect NICE CG74. 
Further research is needed, involving comparisons of modern wound dressings. 
Key reference 
Dumville JC, Walter CJ, Sharp CA et al. (2011) Dressings for the prevention of surgical site infection. 
Cochrane Database of Systematic Reviews issue 7: CD003091 
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Silver nylon dressings 
An RCT (n=110) in Florida, USA by Krieger et al. (2011) evaluated silver nylon dressings for 
preventing surgical site infection. Patients at a university-based tertiary referral centre, 
undergoing elective colorectal surgery with an anticipated abdominal incision length of at least 
3 cm, were included. Exclusion criteria were: known allergy to silver; signs of abdominal wall 
infection; conditions preventing full skin closure during the operation; presence of abdominal 
mesh; pregnant or lactating women; and receipt of antibiotics within 1 week of surgery. 
Patients were randomised to a silver nylon or gauze dressing, which was applied in the 
operating room after surgery. All patients underwent a standard preoperative procedure 
including administration of antibiotics 30–60 minutes before surgery (ertapenem, or an 
alternative in people with penicillin allergy) but no mechanical bowel preparation (except for 
left colon or rectal surgery). Patients were followed up by appointment 7–10 days after 
surgery and by telephone after 30 days. Surgical site infection was determined by an 
unblinded physician from the surgical team using the US Centers for Disease Control and 
Prevention guidelines.  
For the primary outcome of developing a surgical site infection, the total number of infections 
was lower with silver nylon dressings (7/55; 13%) than with gauze (18/54; 33%; p=0.011). A 
multivariate analysis excluded the possibility that other risk factors (such as diabetes, 
smoking or obesity) may have been predictors of infection. 
Limitations of the evidence included that:  • the silver dressing was compared with gauze, therefore performance versus a modern 
dressing could not be gauged • surgical site infection was diagnosed by an unblinded member of the operating team, 
which may have introduced bias • although incision length was used to recruit patients, this was not measured for every 
patient. 
The evidence suggests that silver nylon dressings appear be more effective than gauze in 
preventing surgical site infections. Due to the limitations noted, this evidence is unlikely to 
affect NICE CG74. Further research is needed to compare silver dressings with other modern 
wound dressings used in current practice. 
Key reference 
Krieger BR, Davis DM, Sanchez JE et al. (2011) The use of silver nylon in preventing surgical site 
infections following colon and rectal surgery. Diseases of the Colon & Rectum 54: 1014–9 
Wound closure methods 
NICE CG74 does not make any recommendations about specific types of wound closure in 
preventing surgical site infection. 
Staples versus sutures 
A Cochrane review by Biancari and Tiozzo (2012) compared surgical site infection rates 
after the use of staples or sutures. RCTs comparing staples with any type of suture for wound 
closure after saphenous vein harvesting (excluding endoscopic vein harvest) for coronary 
artery bypass grafting, were included. Other methods of wound closure such as glue were 
excluded. A total of 4 studies were identified, but only 3 studies (148 wounds closed with 
staples, 175 closed with sutures) were included in the meta-analysis (the 4th
No significant difference was seen in the primary outcome of surgical site infection rate (as 
defined by individual trial authors) between the use of staples (16/148; 10.8%) and sutures 
(14/174; 8%) for wound closure (RR=1.20, 95% CI 0.60 to 2.39, p=0.6).  
 study used 
staples to close one half of the wound, and sutures to close the other half, so was excluded). 
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Limitations of the evidence included that:  • only leg wounds after saphenous vein harvest were included, therefore results may not 
be transferable to other types of wound or surgery • all studies were published in or before 2000 and newer products may now be in use • the limited patient numbers may not be sufficient to detect clinically significant differences 
in infection rate • the risk of bias in the included studies was reported to be high • no data were provided about the experience of the surgeons performing the procedure 
and wound closure. 
The authors concluded that there appears to be no evidence of a difference in the risk of 
surgical site infection when leg wounds are closed with staples or with sutures after vein 
harvesting for coronary artery bypass grafting. This evidence is therefore unlikely to affect 
NICE CG74, but additional research focusing on other specific patient groups may be useful. 
Key reference 
Biancari F, Tiozzo V (2012) Staples versus sutures for closing leg wounds after vein graft harvesting for 
coronary artery bypass surgery. Cochrane Database of Systematic Reviews issue 5: CD008057 
Antimicrobial sutures 
Two systematic reviews recently investigated the effect of antimicrobial-coated sutures on 
surgical site infections. 
A systematic review and meta-analysis by Wang et al. (2013) examined RCTs comparing 
sutures coated with triclosan (a broad-spectrum antiseptic agent) versus conventional 
uncoated sutures in preventing surgical site infections. A total of 17 RCTs (n=3720) were 
identified. 
For the primary outcome of incidence of surgical site infection, from a fixed-effects model, 
triclosan-coated sutures appeared to significantly reduce infection rate versus uncoated 
sutures (RR=0.70, 95% CI 0.57 to 0.85, p<0.001; 17 RCTs, n=3720). Subanalyses by type of 
surgical procedure suggested that the effect was only significant with abdominal surgery 
(RR=0.69, 95% CI 0.50 to 0.97, p=0.03; 7 RCTs, n=1562), and not with breast (p=0.114; 
3 RCTs, n=268) or cardiac surgery (p=0.18; 3 RCTs, n=933).  
Limitations of the evidence included that:  • not all trials used diagnostic criteria for surgical site infection as set out by the US Centers 
for Disease Control and Prevention • some trials used silk sutures as the comparator, which are not used in the UK • only 3 trials were assessed as low risk of bias, with the remainder of uncertain or high risk 
of bias • surgical site infection was not a primary end point in 3 trials • there was heterogeneity among the trials in the type of patients and surgical procedures 
included. 
A second systematic review and meta-analysis by Edmiston et al. (2013) also examined 
triclosan-coated sutures in preventing surgical site infections. A total of 13 RCTs (n=3568) 
were identified. Although the review by Edmiston et al. did not include all of the trials covered 
by the Wang et al. (2013) review, it did include 1 additional recent trial of colorectal surgery. 
For the primary outcome of surgical site infection, meta-analysis of the 13 included trials 
showed a significant reduction in risk of infection with triclosan-coated versus uncoated 
sutures in both a fixed effects model (RR=0.73, 95% CI 0.59 to 0.91, p=0.005) and a random 
effects model (RR=0.69, 95% CI 0.53 to 0.92, p=0.011). The trial not included by the Wang et 
al. (2013) review indicated a significant effect of coated sutures among patients undergoing 
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colorectal surgery, consistent with the subgroup analysis by Wang et al. (2013) that reported 
a significant effect of coated sutures in reducing infection after abdominal surgery. 
Limitations of the evidence included that:  • a comprehensive quality assessment of every trial included was not performed (scoring 
based on Oxford Centre for Evidence-based Medicine criteria indicated that 8 trials were 
level 1b evidence, and 5 trials were lower than level 1b) • not all studies used diagnostic criteria for surgical site infection as set out by the US 
Centers for Disease Control and Prevention • reporting of antimicrobial prophylaxis, and glycaemic and body temperature control, was 
inconsistent across trials • patient risk factors were not addressed by the included trials. 
Taken together, the evidence suggests that antimicrobial-coated sutures may reduce surgical 
site infection risk versus uncoated sutures, although this effect may be specific to particular 
types of surgery (such as abdominal procedures). This evidence may, therefore, have a 
potential impact on NICE CG74, however details of any impact are outside the scope of the 
Evidence Update. Decisions on how the new evidence may impact guidance will not be 
possible until the guidance is reviewed by NICE following its published processes and 
methods. 
A large RCT investigating the reduction of surgical site infection with triclosan-coated sutures 
in patients undergoing hip or knee replacement is currently underway in the UK. This is 
consistent with the need for further data as set out in the research recommendation in NICE 
CG74 about which closure methods reduce surgical site infection. 
Key references 
Edmiston CE, Daoud FC, Leaper DJ (2013) Is there an evidence-based argument for embracing an 
antimicrobial (triclosan)-coated suture technology to reduce the risk for surgical-site infections?: A meta-
analysis. Surgery 154: 89–100 
Wang ZX, Jiang CP, Cao Y et al. (2013) Systematic review and meta-analysis of triclosan-coated 
sutures for the prevention of surgical-site infection. British Journal of Surgery 100: 465–73 
Minimally invasive surgery 
NICE CG74 does not make any recommendations about the use of minimally invasive 
surgery in preventing surgical site infection. Two systematic reviews recently examined the 
effect of laparoscopy on postoperative infections. 
A systematic review and meta-analysis by Shabanzadeh and Sorensen (2012) investigated 
surgical site infection rate after laparoscopy in obese patients. RCTs and observational 
studies of obese patients (defined as body mass index of 30 or more, or an International 
Classification of Disease diagnosis of obesity or morbid obesity) comparing the effect of 
laparoscopic versus open surgery on surgical site infection were included. Infection was 
defined as the presence of pus, or a superficial, deep, or organ space infection (according to 
the US Centers for Disease Control and Prevention criteria) in the 30 days after surgery. A 
total of 8 RCTs (n=615) and 36 observational studies (n=58,755) were included. The RCTs 
were all of bariatric surgery (except 1 of appendicectomy), whereas the observational studies 
examined a wider range of procedures (cholecystectomy, appendicectomy, bariatric, hernia, 
colorectal, and general surgery).  
Separate meta-analyses were performed of the RCTs and of the observational studies. A 
significantly lower rate of surgical site infection was seen after laparoscopy than open surgery 
in both of these analyses (RCTs: odds ratio=0.19, 95% CI 0.08 to 0.45, p=0.0002; 
observational studies: odds ratio=0.33, 95% CI 0.26 to 0.42, p=0.00001).  
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Limitations of the evidence included that:  • inconsistent (or unreported) definitions of surgical site infection were used across the 
studies • none of the RCTs were set up to assess specifically the difference in surgical site 
infections between laparoscopic and open surgery (and may therefore have been 
underpowered) • there were several issues among the observational studies, including different study 
designs, lack of adjustment for confounders, and inconsistent reporting of conversions to 
open surgery.  
A systematic review by Phatak et al. (2012) examined different types of intervention 
(including laparoscopy) and their effects on surgical site infections after colorectal surgery. 
Systematic reviews from the Cochrane database evaluating interventions (other than 
antibiotics) to prevent surgical site infections after colorectal surgery were included. A total of 
9 Cochrane reviews were identified, covering: anastomotic technique (2 reviews), mechanical 
bowel preparation, preoperative chlorhexidine bathing, early postoperative feeding, adhesive 
drapes, diverting ileostomy, use of drains, and laparoscopic versus open surgery. Bayesian 
meta-analysis was then used to re-analyse data from the Cochrane reviews. Bayesian 
methods can provide more detailed interpretation of the evidence base, such as the 
probability of a specific level of treatment effect after an intervention (for example, at least a 
20% reduction in surgical site infections). 
After standard meta-analysis, 2 of the interventions identified were shown to significantly 
reduce the risk of surgical site infections: laparoscopic colorectal surgery (RR=0.53, 95% CI 
0.37 to 0.77, p=0.0007), and not using adhesive drapes (RR=0.81, 95% CI 0.67 to 0.98, 
p=0.03). However, from Bayesian analysis, only laparoscopy had a high probability (99%) of 
bringing about a greater than 20% reduction in surgical site infections. 
Limitations of the evidence included that:  • surgical site infections were not the primary outcome of many trials included in the 
Cochrane reviews • the Bayesian analyses only focused on 1 outcome (surgical site infections) and did not 
consider other potential benefits and harms • only reviews from the Cochrane database were included • despite the value of Bayesian analysis it cannot overcome methodological issues with the 
original trials. 
Taken together, the evidence suggests that laparoscopy appears to be associated with lower 
rates of surgical site infection than open surgery among some subgroups; namely, obese 
patients, and those undergoing colorectal surgery. However, reduced rates of infection may 
not be a primary reason to undertake minimally invasive surgery. Other criteria and risk 
factors should also contribute to patient selection for laparoscopy. This evidence is therefore 
unlikely to affect NICE CG74. 
Key references 
Phatak UR, Pedroza C, Millas SG et al. (2012) Revisiting the effectiveness of interventions to decrease 
surgical site infections in colorectal surgery: a Bayesian perspective. Surgery 152: 202–11 
Shabanzadeh DM, Sorensen LT (2012) Laparoscopic surgery compared with open surgery decreases 
surgical site infection in obese patients: a systematic review and meta-analysis. Annals of Surgery 256: 
934–45 
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Wound-edge protection devices 
NICE CG74 does not make any recommendations about the use of ‘wound edge protection 
devices’ (equipment used in abdominal surgery to protect the incision edges, comprising a 
semi-rigid plastic ring inserted into the incision with drapes attached to the circumference; 
also known as ‘wound guards’). 
A systematic review and meta-analysis by Gheorghe et al. (2012) investigated the effect of 
wound guards on surgical site infections after open abdominal surgery. Controlled trials, 
prospective cohort studies, and case control studies of patients undergoing elective or 
emergency open abdominal surgery, comparing wound guards with control, were included. 
Any wound guard device in which incision edges were covered with an impervious plastic 
sheet was eligible. Exclusion criteria were studies examining other devices such as adhesive 
drapes (unless wound guards were also assessed), and those in which surgical site infections 
were defined only in terms of bacteria cultured or enumerated. A total of 12 studies (10 RCTs 
and 2 controlled trials; n=1933) were identified. Three of the trials involved generic abdominal 
surgery, 2 were of appendicectomies, and the remainder mostly involved colorectal surgery.  
The authors indicated that none of the included studies were of sufficient quality to be 
included in a formal meta-analysis. However, an exploratory meta-analysis using a random 
effects model suggested a potentially significant benefit of wound guards in reducing surgical 
site infection risk (RR=0.60, 95% CI 0.41 to 0.86, p=0.005).  
Limitations of the evidence included that:  • the definition of surgical site infection varied considerably across the trials (only 2 used 
recognised definitions, with trial authors using their own definitions in the remainder) • all of the included trials were assessed as being at medium or high risk of bias • the type of wound guard used differed among studies, with the 3 most recent trials using 
a different device to earlier studies • adjustment for risk-factors for surgical site infection was not widely performed, particularly 
in the older trials.  
The authors concluded that wound-edge protection devices may reduce the surgical site 
infection rate after open abdominal surgery, but the current lack of high-quality studies means 
that more research is needed. This evidence is unlikely to affect NICE CG74. 
A large RCT investigating the effect of wound-edge protection devices on surgical site 
infection is currently underway in the UK. 
Key reference 
Gheorghe A, Calvert M, Pinkney TD et al. (2012) Systematic review of the clinical effectiveness of 
wound-edge protection devices in reducing surgical site infection in patients undergoing open abdominal 
surgery. Annals of Surgery 255: 1017–29 
1.4 Postoperative phase 
Negative pressure wound therapy (NPWT) 
NICE CG74 does not make any recommendations about the use of NPWT in preventing 
surgical site infection. Two RCTs recently investigated the use of NPWT in different patient 
groups. 
An RCT (n=81) in Washington DC, United States by Masden et al. (2012) examined the 
effect of NPWT on surgical site infection rates in patients with multiple comorbidities. Patients 
presenting to a single tertiary wound-healing centre (who were often referred after failed care 
of their wounds by other centres), for closure of abdominal or lower limb wounds, were 
included. Patients with adhesive tape allergies or any other potential for intolerance to NPWT, 
 Evidence Update 43 – Surgical site infection (June 2013) 24 
and those with amputations distal to the forefoot (NPWT dressings are not easily applied to 
small irregular surfaces), were excluded. All wounds were initially closed with polypropylene 
sutures and staples, and wrapped in gauze. Patients were then randomised to either NPWT 
or to control (dry dressing with a non-adhesive silicone layer plus a silver layer). Wounds 
were examined by blinded researchers at 3 days, and then at the first and any subsequent 
outpatient visits; average follow-up was 113 days. Infection was defined as mild (erythema, 
inflammation) or severe (purulence, fever, leucocytosis).  
For the primary outcome of wound infection, there was no significant difference between the 
NPWT group (3/44; 6.8%) and control group (5/37; 13.5%, p=0.46). Limitations of the 
evidence included the relatively small number of patients, and the use of a non-adhesive 
silicone dressing plus silver layer in the control group, which may not represent the type of 
dressing used in wider clinical practice. 
A second, multicentre RCT (n=249 patients, 263 fractures) in the United States by Stannard 
et al. (2012) investigated the effect of NPWT on infection rate after lower limb fracture. 
Patients from 4 centres with blunt, high-risk, high-energy trauma (tibial plateau, pilon, or 
calcaneus fracture) needing surgical stabilisation were included. Open fractures, or fractures 
operated on at least 16 days after injury (21 days for pilon fractures), were excluded. After 
open reduction and internal fixation of fractures, patients were then randomised to either 
NPWT or standard dressing. Dressings or NPWT were applied in the operating room, with 
dressings changed on day 2, then every 1 or 2 days. Patients were discharged once wound 
drainage was minimal. Primary outcome data for acute infection (during hospitalisation) and 
late infection were recorded. Infection was defined using a combination of clinical observation 
(presence of pus, erythema, fever, chills) and laboratory data.  
Significantly more infections were seen in the standard dressings group (23/122; 19%) than 
the NPWT group (14/141; 10%; p=0.049), and risk of infection was greater with standard 
dressings (RR=1.9, 95% 1.03 to 3.55). The authors also noted that patients in the NPWT 
group were discharged 0.5 days earlier than those in the dressings group (although this was 
non-significant, p=0.103), which may suggest that costs of NPWT could be offset by reduced 
hospital stays.  
Limitations of the evidence included that:  • length of follow-up was not clear • 3 very different fracture types were examined, therefore results may not necessarily be 
extrapolated to individual types • patients from 4 centres were included, which may have introduced heterogeneity of 
treatment and care • trauma can be variable in terms of injury mechanism and the nature of fractures. 
Taken together, the evidence suggests that NPWT appears to reduce the surgical site 
infection rate after invasive treatment of lower limb trauma, but may be less effective in other 
patient groups such as those with multiple comorbidities. Limitations with current data mean 
that more research is needed to confirm findings and to further examine the groups of 
patients who may benefit from NPWT, therefore this evidence is unlikely to affect NICE CG74. 
Key references 
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2 New evidence uncertainties 
During the development of the Evidence Update, the following evidence uncertainties were 
identified for the UK Database of Uncertainties about the Effects of Treatments (UK DUETs).  
Preoperative phase  • Preoperative bathing or showering with skin antiseptics to prevent surgical site infection • Preoperative hair removal to reduce surgical site infection  • Removal of nail polish and finger rings to prevent surgical infection • Local antibiotic and antiseptic prophylaxis in cardiac implantable electronic device 
implantation  • Antibiotic prophylaxis for hernia repair • Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery 
Intraoperative phase • Disposable surgical face masks for preventing surgical wound infection in clean surgery • Skin preparation for preventing infection following caesarean section • Scalpel versus electrosurgery for abdominal incisions • Dressings for the prevention of surgical site infection • Staples versus sutures for closing leg wounds after vein graft harvesting for coronary 
artery bypass surgery • Wound edge protectors to reduce surgical site infection in open abdominal surgery 
Further evidence uncertainties for surgical site infection can be found in the UK DUETs 
database and in the NICE research recommendations database. 
UK DUETs was established to publish uncertainties about the effects of treatments 
that cannot currently be answered by referring to reliable up-to-date systematic reviews of 
existing research evidence. 
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Appendix A: Methodology 
Scope 
The scope of this Evidence Update is taken from the scope of the reference guidance: • Surgical site infection. NICE clinical guideline 74 (2008).  
Searches 
The literature was searched to identify studies and reviews relevant to the scope. Searches 
were conducted of the following databases, covering the dates 13 April 2011 (the end of the 
search period for the latest review of the need to update NICE clinical guideline 74) to 
8 January 2013: • CDSR (Cochrane Database of Systematic Reviews) • CENTRAL (Cochrane Central Register of Controlled Trials) • CINAHL (Cumulative Index to Nursing and Allied Health Literature) • DARE (Database of Abstracts of Reviews of Effects) • EMBASE (Excerpta Medica database) • HTA (Health Technology Assessment) database • MEDLINE (Medical Literature Analysis and Retrieval System Online)  • MEDLINE In-Process • NHS EED (Economic Evaluation Database) 
Table 1 provides details of the MEDLINE search strategy used (based on the search strategy 
for the reference guidance), which was adapted to search the other databases listed above. 
The search strategy was used in conjunction with validated Scottish Intercollegiate Guidelines 
Network search filters for RCTs and systematic reviews. 
Additionally, 1 study (Edmiston et al. 2013) was identified outside of the literature search. 
Figure 1 provides details of the evidence selection process. The long list of evidence 
excluded after review by the Chair of the EUAG, and the full search strategies, are available 
on request from contactus@evidence.nhs.uk 
There is more information about how NICE Evidence Updates are developed on the NICE 
Evidence Services website. 
 
Table 1 MEDLINE search strategy (adapted for individual databases) 
 
1 Surgical Wound Infection/ 
2 
((surger$ or surgical$) adj3 (infect$ or 
sepsis or septic$ or dehiscen$ or 
separat$)).ti,ab. 
3 
((wound? or incision$) adj3 (infect$ or 
sepsis or septic$ or dehiscen$ or 
separat$)).ti,ab. 
4 Wound Infection/ 
5 (SSI or SSTI).ti,ab. 
6 Surgical Wound Dehiscence/ 
7 or/1-6 
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Figure 1 Flow chart of the evidence selection process 
 
  
 
 
EUAG – Evidence Update Advisory Group 
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